These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9807197)

  • 41. "We are on the threshold of an era when breast cancer ... can be prevented".
    Pike M
    Oncology (Williston Park); 1991 May; 5(5):14, 16, 21-2. PubMed ID: 1831996
    [No Abstract]   [Full Text] [Related]  

  • 42. Estrogen use and endometrial cancer.
    Stolley PD; Davies JL
    N Engl J Med; 1979 Apr; 300(16):923. PubMed ID: 218103
    [No Abstract]   [Full Text] [Related]  

  • 43. Estrogen plus progestin in postmenopausal women--act II.
    MacDonald PC
    N Engl J Med; 1986 Oct; 315(15):959-61. PubMed ID: 3762597
    [No Abstract]   [Full Text] [Related]  

  • 44. [The role of sex steroids for genesis of breast and endometrial cancer].
    Distler W
    Gynakologe; 1993 Apr; 26(2):94-9. PubMed ID: 8508990
    [No Abstract]   [Full Text] [Related]  

  • 45. Endometrial cancer and hormone replacement therapy - where does the risk lie?
    Future Oncol; 2005 Jun; 1(3):293. PubMed ID: 16556001
    [No Abstract]   [Full Text] [Related]  

  • 46. Cancer and other risk factors with estrogen replacement.
    Astedt B
    Acta Obstet Gynecol Scand Suppl; 1987; 140():46-51. PubMed ID: 3475937
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hormone replacement therapy and cancer risk].
    Matsushita H; Wakatsuki A
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():805-9. PubMed ID: 23156354
    [No Abstract]   [Full Text] [Related]  

  • 48. The "red queen" and endometrial hyperplasia.
    Gambrell RD
    Fertil Steril; 1994 Feb; 61(2):401-2. PubMed ID: 8299806
    [No Abstract]   [Full Text] [Related]  

  • 49. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
    Meuwissen JH; Klinkhamer PJ; Brölmann HA; Wiegerinck MA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1473. PubMed ID: 8361563
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hormone replacement therapy: do we have to choose between breast and endometrial cancer?].
    Jamin C
    Gynecol Obstet Fertil; 2012 Apr; 40(4):199-200. PubMed ID: 22464059
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hormone replacement therapy and endometrial cancer].
    Concin H; Sommerlechner M
    Gynakol Geburtshilfliche Rundsch; 1998; 38(2):93-5. PubMed ID: 9815525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endometrial sampling for women on peri-menopausal hormone replacement therapy.
    Kovacs GT; Burger HG
    Maturitas; 1988 Dec; 10(4):259-62. PubMed ID: 3226335
    [No Abstract]   [Full Text] [Related]  

  • 53. Estrogen and cancer.
    Creasman WT
    Gynecol Oncol; 2002 Jul; 86(1):1-9. PubMed ID: 12079291
    [No Abstract]   [Full Text] [Related]  

  • 54. Hormone replacement therapy and cancer.
    Mack TM
    Baillieres Clin Endocrinol Metab; 1993 Jan; 7(1):113-49. PubMed ID: 8435049
    [No Abstract]   [Full Text] [Related]  

  • 55. Breast cancer risk and pretreatment estrogen levels.
    Pines A
    Climacteric; 2014 Feb; 17(1):103-4. PubMed ID: 24571033
    [No Abstract]   [Full Text] [Related]  

  • 56. Hormone replacement therapy.
    Rosenblatt J; Murtagh J
    Aust Fam Physician; 1992 Sep; 21(9):1345-6. PubMed ID: 1417565
    [No Abstract]   [Full Text] [Related]  

  • 57. Wanted: more evidence on whether estrogen replacement causes cancer.
    Naftolin F; Rutherford TJ; Chambers JT; Carcangiu ML
    J Soc Gynecol Investig; 1997; 4(2):57. PubMed ID: 9101461
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hormonal substitution in climacteric symptoms after cancer treatment].
    Bergkvist L; Frankendal B; Samsioe G; Silfverstolpe G
    Lakartidningen; 1989 May; 86(19):1798-9, 1801-2, 1804. PubMed ID: 2733484
    [No Abstract]   [Full Text] [Related]  

  • 59. Gynaecology. Hormonal interventions and cancer risk.
    Neven P; De Muylder X
    Lancet; 1995 Dec 23-30; 346 Suppl():s8. PubMed ID: 9454051
    [No Abstract]   [Full Text] [Related]  

  • 60. NHLBI stops estrogen plus progestin trial.
    Cockey CD
    AWHONN Lifelines; 2002; 6(4):299-307. PubMed ID: 12239785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.